V
Virogin Biotech
Virogin Biotech is an antineoplastic drug developer
About Virogin Biotech
Virogin.com operates in the digital space, providing essential technical storage and access services. In simpler terms, they offer a platform where users or subscribers can store and access their data securely. This service is particularly useful for individuals or businesses that need to manage large amounts of data or require secure storage for sensitive information.
The company's business model revolves around offering these storage services to subscribers. They generate revenue by charging these subscribers a fee for the storage and access services they provide. This fee is typically based on the amount of storage space used or the level of access required.
Virogin.com operates in a market that is becoming increasingly important as more and more businesses move their operations online and the need for secure, reliable data storage grows. Their clients range from individual users who need to store personal data to large corporations that require secure storage for vast amounts of business data.
One of the key selling points for Virogin.com is their commitment to privacy and security. They state that they only use the stored data for legitimate purposes, such as enabling the use of their service or carrying out the transmission of a communication. They also use the data for statistical purposes, but this is done anonymously to protect the privacy of their users.
In conclusion, Virogin.com is a digital storage service provider that caters to a wide range of clients, from individuals to large corporations. They operate in a growing market and generate revenue by charging for their storage and access services.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Richmond, Canada
- Employees
- 29
- Open positions
- None listed
- Dealroom signal
- 64.8/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Sep 2021 | $120M | $480M | China Life Healthcare Fund | ↗ |
| SERIES DOther financing | May 2021 | $80M | $320M | GP Capital · Pan-Lin Asset Management · Forebright Capital · China Structural Reform Fund | ↗ |
Growth signals
Latest recorded traffic for Virogin Biotech is 4.3K monthly website visits, up 394.3% over the last three months. Virogin Biotech's team declined 12.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A5 investors entered at this stage
- GCGP Capital
- FIFudan University Ningbo Research Institute
Sangel Capital- DIDahua Investment
- SCSinopharm Capital
Series B and later8 investors entered at this stage
CDH Investments- CCChina Merchants Capital
Korea Investment Partners- LMLinden Asset Management
Pan-Lin Asset Management
Forebright Capital
China Structural Reform Fund
China Life Healthcare Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Virogin Biotech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Virogin Biotech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








